Your session is about to expire
← Back to Search
Combination Chemotherapy + Monoclonal Antibody for Acute Myeloid Leukemia
Study Summary
This trial is comparing the effectiveness of chemotherapy with or without monoclonal antibody therapy for treating patients with refractory or relapsed acute myelogenous leukemia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I will use effective birth control during and for 1 month after the study.I have a serious infection that isn't getting better with treatment.I have been diagnosed with acute myelogenous leukemia.My bilirubin level is above 2.0 mg/dL, not due to Gilbert's disease or leukemia.My heart's left ventricle isn't working properly.I haven't had recent serious heart problems.I am 18 years old or older.I can perform most of my daily activities without assistance.I do not have leukemia in my brain or spinal cord.I do not have any other cancer that needs treatment.My health condition is currently stable.I have severe heart disease.My blood, liver, kidney, and heart meet the trial's health requirements.I do not have leukemia in an advanced stage.I am currently receiving treatment for cancer.My organs are not working properly.I do not have any serious infections that aren't controlled by medication.My organs are functioning well.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any participants needed for this clinical trial?
"The clinical trial in question is not recruiting patients at this time, based on the information available on clinicaltrials.gov. This particular study was first posted on March 1st, 2000 and last updated November 5th, 2013. Although this specific research project isn't looking for candidates presently, there are 1519 other studies that are currently conducting recruitment drives."
Does this remedy have the FDA's go-ahead?
"This Phase 3 trial has provided some evidence of efficacy and multiple rounds of safety data, so the Power team rates the safety of this treatment as a 3."
In how many hospitals is this research project being conducted?
"So far, 44 enrolment centres have been announced for this trial, which include the Ireland Cancer Center in Cleveland, Milton S. Hershey Medical Center in Hershey, and Sutter Cancer Center in Sacramento."
Share this study with friends
Copy Link
Messenger